In vivo experiments demonstrated that exosomes from respiratory syncytial virus (RSV)-treated bone marrow MSCs enhanced the inflammatory response in RSV-infected mice, indicated by elevated serum inflammatory cytokines, lung dysfunction, airway inflammation, and increased mucus secretion.
[Scientific Reports]
